Home

 

Home >> Home

Tuesday 10th January 2006
Novozymes GroPep starts Phase 1 infertility trial

Monday 19th December 2005
Novozymes GroPep completes final milestone of the PATH Malaria Vaccine

Wednesday 14th December 2005
Novozymes GroPep to pursue promising asthma drug following preclinical study results

2004-2005 Annual Report
Download the latest Annual
Report including Financial
Statements.

Australian Stock Exchange
Novozymes GroPep’s latest stock price.
(External site)






 

 
 

Novozymes GroPep: A biotechnology company serving the research, cell culture, and IGF markets.
Copyright  •  Disclaimer  •  Privacy  •  Download Acrobat Reader